Be a Smart Investor
Wednesday, October 11, 2017
Pharma business is key to Johnson & Johnson: Jefferies analyst
Jeffrey Holford, Jefferies, discusses upgrading Johnson & Johnson after acquiring Actelion.
from Mergers and Acquisitions http://ift.tt/2xz7CTC
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment